内部人交易雷达

美国 · SEC Form 4 · 快照日期: 2026-10-18 · 构建时间: 2026-10-18 · English

← 美国市场 · 覆盖记录

美国 · SEC FORM 4

Zai Lab Ltd

ZLAB · Nasdaq · CIK 0001704292 · Healthcare · Biotechnology

内部人信号

当前没有活跃买入信号

1 qualifying P purchase group
当前 180 天评分窗口

44 同一窗口内观察到的 Form 4 交易行
14 sales · 29 期权、代扣税、授予、赠与或其他交易行

最近一次合资格买入2026-07-01 · GAYNOR RICHARD · $33.1K

为什么没有活跃信号?

买入活动存在
近期买入1 qualifying line group(s)
近期卖出中等
买入信号状态未激活
评分构成

活跃窗口内没有合资格买入,因此不计算分数。缺失的输入不会被当作零分或看空信号。

Cluster未计算
买入规模未计算
角色未计算
近期性未计算
确信度未计算

为什么没有分数?

  • 没有合资格公开市场买入可提供聚集度、规模、角色、近期性或确信度输入。
  • 卖出及其他 Form 4 活动继续作为背景显示,不会形成负分。

卖出和其他 Form 4 活动会单独显示,不会形成负面买入信号。没有买入不会被评分为看空。

内部人活动时间轴

申报人轨道展示最近 180 天。符号形状区分交易类型;卖出仅作为背景。

AprMayJunJulAugSepOct
Du YingChairperson & CEO
○○○○○▼○▼○○○○
Chen YajingChief Financial Officer
○▼▼○○▼○○
Lis WilliamDirector
○▼▼
GAYNOR RICHARDDirector
○●
Edmondson Frazor Titus IIIChief Legal Officer
○▼
WIRTH PETERDirector
○
● 买入▼ 卖出○ 其他

Showing the six most active owners; 5 additional owner(s) remain in Form 4 申报证据.

买方广度与集中度

合资格买方1
买入集中度100%最大买方: GAYNOR RICHARD · $33.1K
聚集买入 · 15天1 insider峰值活动: 2026-07-01–2026-07-01

Roles in the peak window: Director. Concentration uses priced qualifying P lines only and does not change the saved score.

信号历史

暂无已记录的活跃信号快照

Scores are archived only when the company qualifies for a published US buy-signal snapshot. 最近一次合资格买入: 2026-07-01 · GAYNOR RICHARD.

近期 Form 4 活动

2买入
40卖出
58其他 Form 4 交易行
50SEC 申报 · 365天
买入1 qualifying P line(s) · 180 days
卖出14 sale line(s) · 仅供背景
其他29 exercise / withholding / award / gift / other lines
10b5-1/计划交易Not assessed

P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.

市场背景

该股票尚未获取市场背景。每日任务会轮转处理美国股票池。

空头余额

空头余额是券商向 FINRA 申报的外部背景数据,不影响内部人信号。

空头股数
7,149,727
上期报告
8,156,879
日均成交量
791,166
回补天数
9.0

FINRA 结算日:2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数,每月两个结算日之后约一周公布;不是占已发行股份的比例。

历史股票买入

Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.

Transaction dateReporting owner类型证券股数平均价格估算金额来源
2026-07-01GAYNOR RICHARD买入 (P)American Depositary Shares1,736USD 19.05USD 33,071SEC 申报 ↗
2026-03-17GAYNOR RICHARD买入 (P)American Depositary Shares1,731USD 18.91USD 32,733SEC 申报 ↗
2025-09-10Smiley Joshua L买入 (P)American Depositary Shares10,000USD 28.91USD 289,100SEC 申报 ↗
2024-05-13Smiley Joshua L买入 (P)American Depositary Shares3,000USD 21.40USD 64,200SEC 申报 ↗
2024-03-01Smiley Joshua L买入 (P)American Depositary Shares3,000USD 20.83USD 62,490SEC 申报 ↗
2023-12-14Smiley Joshua L买入 (P)American Depositary Shares4,000USD 29.90USD 119,600SEC 申报 ↗
2023-11-16Smiley Joshua L买入 (P)American Depositary Shares5,000USD 26.93USD 134,650SEC 申报 ↗
2021-12-08WIRTH PETER买入 (P)American Depositary Shares4,000USD 71.36USD 285,440SEC 申报 ↗
2021-12-08WIRTH PETER买入 (P)Ordinary Shares4,000USD 71.36USD 285,440SEC 申报 ↗

Form 4 申报证据

100 transaction lines in the latest 365-day window; 587 in local history.

日期申报人类型证券股数平均价格估算金额来源
2026-10-01Chen Yajing期权行权/转换 (M)American Depositary Shares920USD —USD —SEC 申报 ↗
2026-10-01Chen Yajing代扣税 (F)American Depositary Shares315USD 25.50USD 8,032SEC 申报 ↗
2026-08-19Chen Yajing卖出 (S)American Depositary Shares260USD 27.00USD 7,020SEC 申报 ↗
展开近期 Form 4 证据 (30 grouped rows)
日期申报人类型证券股数平均价格估算金额来源
2026-10-01Chen Yajing期权行权/转换 (M)American Depositary Shares920USD —USD —SEC 申报 ↗
2026-10-01Chen Yajing代扣税 (F)American Depositary Shares315USD 25.50USD 8,032SEC 申报 ↗
2026-08-19Chen Yajing卖出 (S)American Depositary Shares260USD 27.00USD 7,020SEC 申报 ↗
2026-08-14Chen Yajing期权行权/转换 (M)American Depositary Shares1,250USD —USD —SEC 申报 ↗
2026-08-14Chen Yajing代扣税 (F)American Depositary Shares427USD 25.90USD 11,059SEC 申报 ↗
2026-08-12Lis William卖出 (S)American Depositary Shares8,506USD 25.00USD 212,650SEC 申报 ↗
2026-08-11Chen Yajing卖出 (S)American Depositary Shares619USD 25.00USD 15,475SEC 申报 ↗
2026-07-02Du Ying期权行权/转换 (M)American Depositary Shares11,048USD —USD —SEC 申报 ↗
2026-07-02Du Ying代扣税 (F)American Depositary Shares4,348USD 19.12USD 83,134SEC 申报 ↗
2026-07-01GAYNOR RICHARD买入 (P)American Depositary Shares1,736USD 19.05USD 33,071SEC 申报 ↗
2026-07-01Du Ying期权行权/转换 (M)American Depositary Shares18,000USD —USD —SEC 申报 ↗
2026-07-01Du Ying代扣税 (F)American Depositary Shares7,083USD 19.15USD 135,639SEC 申报 ↗
2026-06-30Du Ying卖出 (S)American Depositary Shares7,026USD 18.53USD 130,192SEC 申报 ↗
2026-06-29Du Ying期权行权/转换 (M)American Depositary Shares17,970USD —USD —SEC 申报 ↗
2026-06-26Edmondson Frazor Titus III卖出 (S)American Depositary Shares4,103USD 17.46USD 71,638SEC 申报 ↗
2026-06-26Du Ying卖出 (S)American Depositary Shares24,543USD 17.46USD 428,521SEC 申报 ↗
2026-06-26Chen Yajing卖出 (S)American Depositary Shares2,264USD 17.46USD 39,529SEC 申报 ↗
2026-06-25Edmondson Frazor Titus III期权行权/转换 (M)American Depositary Shares14,600USD —USD —SEC 申报 ↗
2026-06-25Du Ying期权行权/转换 (M)American Depositary Shares58,800USD —USD —SEC 申报 ↗
2026-06-25Chen Yajing期权行权/转换 (M)American Depositary Shares6,250USD —USD —SEC 申报 ↗
2026-06-22Lis William卖出 (S)American Depositary Shares7,040USD 18.09USD 127,354SEC 申报 ↗
2026-06-17WIRTH PETER奖励/授予 (A)American Depositary Shares22,371USD 0.00USD 0SEC 申报 ↗
2026-06-17Vounatsos Michel奖励/授予 (A)American Depositary Shares22,371USD 0.00USD 0SEC 申报 ↗
2026-06-17Morrison Scott W奖励/授予 (A)American Depositary Shares22,371USD 0.00USD 0SEC 申报 ↗
2026-06-17MOULDER LEON O JR奖励/授予 (A)American Depositary Shares22,371USD 0.00USD 0SEC 申报 ↗
2026-06-17Lis William奖励/授予 (A)American Depositary Shares22,371USD 0.00USD 0SEC 申报 ↗
2026-06-17Leung Nisa奖励/授予 (A)American Depositary Shares22,371USD 0.00USD 0SEC 申报 ↗
2026-06-17GAYNOR RICHARD奖励/授予 (A)American Depositary Shares22,371USD 0.00USD 0SEC 申报 ↗
2026-06-17DIEKMAN JOHN D奖励/授予 (A)American Depositary Shares22,371USD 0.00USD 0SEC 申报 ↗
2026-05-27Du Ying赠与 (G)American Depositary Shares87,843USD 0.00USD 0SEC 申报 ↗

Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.

快照与身份

快照日期2026-10-18
排名版本US-v1.2
数据质量PASS ELIGIBLE · —
股票代码ZLAB
CIK0001704292
行业Healthcare
细分行业Biotechnology Yahoo Finance
SEC SIC2834 Pharmaceutical Preparations
交易所Nasdaq

数据覆盖

本地 Form 4 历史587 transaction lines from 2021-01-05 to 2026-10-01
9 P purchase lines · 316 S sale lines · 262 other lines
SEC 公司申报打开 SEC 申报 ↗

Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.